dominantly with a single complement determination. Such cross-sectional studies using a limited sample could produce erratic results ifsignificant fluctuations of serum complement levels occurred during the course of rheumatoid arthritis.
In order to determine whether or not such changes of serum complement levels take place during the course of rheumatoid arthritis, a longitudinal clinical and serological study was conducted at University Hospital and Montebello State Hospital, Baltimore, Maryland. Data were obtained which explain the discrepancy of previous publications, and the results are presented below.
Material 43 patients with classical or definite rheumatoid arthritis (Ropes, Bennett, Cobb, Jacox, and Jessar, 1959) were selected at random for examination at 4-to 8-week intervals in the Arthritis Clinic of University Hospital and on the wards of the Montebello State Hospital, Baltimore, Maryland.
The clinical evaluation and the assessment of disease activity were performed according to a protocol which has already been published in detail (Schubart, Cohen, and Calkins, 1964) . Results of every examination were recorded separately for each patient. Disease activity was classified as active or inactive (remission). Active disease was graded as minimal, moderate, or severe. The patients were divided into groups according to the treatment received during the course of observation; 26 patients were treated with salicylates only, and twelve ) received steroids at some time or another. Steroid treatment consisted of a minimum dose schedule required for partial suppression of disease activity and did not exceed 20 mg. Prednisone per day in any one of the patients. Three patients (Cases 41-43) received gold treatment during the time of observation.
Methods
Serum was obtained at each re-examination. In order to preserve unstable serum constituents, techniques published previously were employed (Schubart, Rothschild, Schroeder, Ewald, and Tuerk, 1963) . Sera were stored at -70°C. The following tests were carried out on every serum:
(1) Serum complement levels were determined and expressed in C'-H50 haemolytic units following the technique of Mayer (1961) . For details see Schubart and others (1963 (2) The latex-fixation test for the demonstration of rheumatoid factor was carried out by a modification of the method of Singer and Plotz (1956) . For details see Schubart, Cohen, and Calkins (1959) .
(3) The thermolabile inhibitor of the rheumatoid factor was determined in the latex-fixation test (see Schubart and others, 1959) .
Concentration of rheumatoid factor and thermolabile inhibitor determined with the F-II LP test were expressed in the following manner (see Table II Fig. 1 . A convincing correlation between serum complement levels and concentration of rheumatoid factor and thermolabile inhibitor did not emerge. Significant fluctuations of serum complement including low and markedly raised values were observed in patients with negative latex-fixation tests as well as in patients with high titres of rheumatoid factor. In many instances marked changes in serum complement were accompanied by fixed titres of rheumatoid factor and thermolabile inhibitor. Inversely, serum complement might remain within the normal range while marked changes in rheumatoid factor concentration occurred (As an example, see Fig. 1 ). group.bmj.com on April 2, 2017 -Published by http://ard.bmj.com/ Downloaded from ANNALS OF THE RHEUMATIC DISEASES correlation with active and inactive disease (Fig. 3) . Significant fluctuations of complement levels occurred in active disease regardless of treatment (no significant difference being seen between the steroid and salicylate groups.) Two patients with permanent remission (observed for a total of 55 months) exhibited only minimal variations of complement levels well within the normal range.
ANNALS OF THE RHEUMATIC DISEASES
Twelve patients (nine treated with salicylates only, three treated with steroids) were found to be in temporary remission at some time or another for a total of 115 months of observation. Significant fluctuation of complement was also seen during remission. The mean complement value obtained during remission was found to be higher than the mean value during the period of active disease in the same group of patients.
Discussion
In rheumatoid arthritis the serum complement system has been studied repeatedly, since it was postulated that an immune mechanism with participation of serum complement might play a role in the pathogenesis of the disease. Early reports indicated that serum complement levels of some patients with rheumatoid arthritis did indeed deviate from normal (Table I) Williams and Law (1958) and Ellis and Felix-Davies (1959) attempted a correlation of the severity of rheumatoid arthritis with serum complement levels; raised levels were found in cases with active disease. Laurell and Grubb (1958) reported normal complement values in 23 cases with rheumatoid arthritis; a clinical classification and correlation with disease activity was not mentioned. In recent reports by Perlick (1962) and Geidel and others (1964) , the majority of cases had reduced serum complement levels.
The disparity of results found among the investigators mentioned above requires further explanation. The data clearly indicate that serum complement levels may be abnormal in some cases with rheumatoid arthritis. Correlation of complement changes with clinical data is difficult since the natural course of the disease may show a large variety of clinical manifestations. These cannot readily be translated into grades of disease activity or severity (Lansbury, 1963) . For this reason, the cases reported in the past may not be comparable. Furthermore, conflicting results can perhaps best be explained by the small number of cases studied in a cross-sectional fashion.
It was, therefore, decided to study patients with rheumatoid arthritis in a longitudinal fashion. Patients were examined at regular intervals (between 4 to 8 weeks) and disease activity was assessed according to a predetermined system. Serum complement levels and concentration of rheumatoid factor and thermolabile inhibitor were determined (Schubart and others, 1964) .
Significant fluctuations in serum complement levels were seen during the course of rheumatoid arthritis. Values ranged between low normal (around 25 C'-H50 units) and significantly raised levels.
Correlation of these complement changes with disease activity did not reveal a consistent pattern. Low or normal complement titres were found frequently at the time of increased disease activity, while at other times raised complement levels seemed to prevail during a comparable period of the illness.
During permanent remission (two cases observed for 55 months), serum complement levels showed modest fluctuations well withjn the range of normal and not exceeding 55 or 30 C'-H50 units; the mean value being comparable to that seen in the control group.
In cases with temporary remissions treated only with salicylates, serum complement levels varied significantly. There was a tendency for complement levels to be higher during temporary remission than during active disease in the same patient (Fig.  3) . Sequential changes of complement in relation to disease activity are illustrated in Fig. 4 (Fig. 3) . The number of these patients was small (three only) though the total time of observation was 238 months. Therefore, it should not be concluded that steroid treatment would be associated with lower complement levels since the complement levels of nine patients with constant disease activity did not differ significantly from those of patients who were treated with salicylates only.
It must be emphasized that the patients in this study received only small doses of steroids (less than 20 mg. Prednisone per day). The effect of larger amounts of steroids or ACTH was not evaluated.
No significant correlation was found when the concentration of rheumatoid factor and thermolabile inhibitor was compared with the serum complement levels. Fluctuations of complement were seen in patients with high titres in the F-IT L.P. test and also in patients with negative tests. Furthermore, serum complement levels remained normal in Case 27 (Fig. 1) when the concentration of rheumatoid factor changed from negative to a titre of 1: 1,280.
There is no question that the serum complement levels may deviate from normal in rheumatoid arthritis. The changes observed in this study suggest no answer to the question whether or not complement consumption through an immune mechanism is taking place or whether complement production is at fault when reduced values are encountered. An increase in complement production or release must be postulated whenever raised values are seen. However, the elevation of serum complement levels may be caused in a non-specific way through inflammatory changes, as was shown by Fischel (1953) . For this reason, studies such as this are of limited value in solving the problem of specificity or pathogenetic significance of abnormal complement levels. Nevertheless, this correlation of clinical and serological data of 925 examinations of 43 patients with rheumatoid arthritis provided some answers:
(1) Previous studies were confirmed, showing that serum complement levels may exhibit significant fluctuations during active disease.
(2) Abnormal complement levels were found to be predominantly raised. (See high means values in Fig. 3 ). However, the significant difference between high and low complement values in a given case exceeding the complement fluctuations of normal controls were the characteristic changes of active rheumatoid arthritis (See Tables III to VIII) . (3) There was no apparent relation between serum complement changes and severity of illness. (4) Serum complement levels remained normal in patients with permanent remission ofrheumatoid arthritis. (5) Changes in concentration of rheumatoid factor and thermolabile inhibitor of the F-Il L.P. test showed no significant correlation with changes in serum complement levels.
The careful study of isolated cases may furnish important leads such as were seen in Case 44 (Fig. 5 ). This patient with classical rheumatoid arthritis and Felty's syndrome (leucopenia, splenomegaly) was found to have reduced complement values when first seen. After a biopsy which was complicated by a staphylococcal infection, the serum complement levels rose to normal. When the patient received blood transfusions in preparation for splenectomy, a precipitate fall in serum complement levels was demonstrated. Simultaneously a slight reduction in the titre of rheumatoid factor was observed in the latex-fixation test. Antinuclear antibodies were demonstrated in the patient's serum using a complement-binding technique. The transfusion was not complicated by any reactions. Careful crossmatching and typing was performed. Following splenectomy the patient's complement returned to normal and has since remained so (Fig. 5) . Pekin and Zvaifler (1962) , Zvaifler and Pekin (1963) , Hedberg (1963 , 1964 ), and Fostiropoulos, Austen, and Bloch (1964 
